Dyne Therapeutics Inc Cash Flow Reinvestment Rate

Latest as of December 2017: 2.73x

Dyne Therapeutics Inc cash flow reinvestment rate. Dyne Therapeutics Inc (DYN) has a Cash Flow Reinvestment Rate of 2.73x as of December 2017, reinvesting $229.00 Million (capex $224.00 Million plus investments $5.00 Million) from operating cash flow of $84.00 Million. See Dyne Therapeutics Inc (DYN) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

2.73x
(Capex + Investments) / Operating CF

Total Reinvested

$229.00 Million
Capex + Investments

Operating Cash Flow

$84.00 Million
USD

Capital Expenditures

$224.00 Million
USD

Cash Flow Reinvestment Rate of Dyne Therapeutics Inc (2007–2017)

Cash flow reinvestment rate of Dyne Therapeutics Inc from 2007 to 2017. Historical reinvestment intensity for Dyne Therapeutics Inc across 8 annual periods. Explore Dyne Therapeutics Inc (DYN) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Dyne Therapeutics Inc Cash Flow Reinvestment Rate by Year (2007–2017)

Dyne Therapeutics Inc cash flow reinvestment rate by year from 2007 to 2017. Year-by-year capital reinvestment analysis for Dyne Therapeutics Inc. For the full cash flow conversion analysis, see Dyne Therapeutics Inc (DYN) cash flow conversion.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2017 0.38x $224.00 Million $585.00 Million $224.00 Million ▼ -20.6%
2016 0.48x $326.00 Million $676.00 Million $326.00 Million ▼ -83.5%
2015 2.93x $275.00 Million $94.00 Million $275.00 Million ▲ +422.4%
2013 0.56x $98.00 Million $175.00 Million $98.00 Million ▼ -28.9%
2010 0.79x $333.00 Million $423.00 Million $333.00 Million —
2009 0.00x $0.00 $135.00 Million $0.00 —
2008 0.00x $0.00 $319.00 Million $0.00 —
2007 0.00x $0.00 $341.00 Million $0.00 —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow